About: Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study (en)
skos:prefLabel	Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study (en)
name	Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study (en)
title	wds:Q64649123-38C663F7-1AD0-4416-AA14-0F0FC021188C
title	An Open Label Conversion Study of Carbidopa-Levodopa (CD-LD) Extended-Release Taken Alone or in Combination With CD-LD Immediate Release to IPX066 Followed by an Open-Label Extension Safety Study of IPX066 in Advanced PD (en)
end time	wds:Q64649123-1837E3C4-7D7F-46A1-87F3-6CF346A59C4C
end time	2013-03-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q64649123-644B6BE4-54DF-428C-98AD-F5A2C222DF80
instance of	clinical trial
start time	wds:Q64649123-218B4983-7A24-4F51-BC1A-712F80EEEE92
start time	2011-08-01 00:00:00Z (xsd:dateTime)
country	wds:Q64649123-52CAF707-8825-49C6-888B-53341E3C0F56
country	United States of America
research site	wds:Q64649123-25CAA542-E0C7-447F-BD7F-701FD1C5149F wds:Q64649123-5DABC686-90B9-4CB4-ACED-B91B30293653 wds:Q64649123-9CCD0E73-A51A-4F31-A44F-BD6576E42925
research site	University of Alabama at Birmingham University of Nevada, Reno School of Medicine Quest Research Institute
research intervention	wds:Q64649123-E8D147AB-11F2-4D1A-A423-C566B5DD8094
research intervention	(S)-(−)-carbidopa monohydrate
minimum age	wds:Q64649123-D19C8E8D-64B0-4480-A487-E9A7674342CC
minimum age	30 (xsd:decimal)
medical condition	wds:Q64649123-7F5A4A44-F9CC-4CCC-93FF-5E8628EC4843
medical condition	Parkinson's disease
number of participants	wds:Q64649123-CEADD056-73B2-4513-A326-0D999EA066FA
number of participants	43 (xsd:decimal)
contributor to the...e work or subject	wds:Q64649123-5EA164D8-F2B7-400D-ACDC-5499B5CDA167
contributor to the...e work or subject	The Michael J. Fox Foundation
study type	wds:Q64649123-CD33030E-EBC0-4F25-967B-42DD01091C97
study type	interventional study
ClinicalTrials.gov ID	wds:Q64649123-BCA10868-8946-4DC2-BB99-B071A7CCE470
ClinicalTrials.gov ID	NCT01411137
clinical trial phase	wds:Q64649123-21FEF8DE-FEEB-4D00-A084-15EB8804F228
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64649123

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software